loader image

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Reading Time: < 1 minute



Yesterday, ICER’s independent appraisal committee, the New England Comparative Effectiveness Public Advisory Council (NE-CEPAC) met to discuss the effectiveness and value of Lykos Therapeutics’ MDMA-assisted therapy for PTSD. We have covered ICER’s ongoing appraisal of MDMA-assisted therapy since late March, when the initial draft evidence report was published. As such, we won’t rehash those…
Source



Source link

share this article
  • This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

  • This field is for validation purposes and should be left unchanged.

latest from the industry
PSYCHEDELICS news

Whitepaper

  • This field is for validation purposes and should be left unchanged.

  • This field is for validation purposes and should be left unchanged.

Use